|
1
|
CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells.
|
Eur J Immunol
|
2001
|
2.13
|
|
2
|
Properties of the avian viral protein p12.
|
J Gen Virol
|
1981
|
1.90
|
|
3
|
Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention.
|
Bone Marrow Transplant
|
2004
|
1.84
|
|
4
|
Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure.
|
Bone Marrow Transplant
|
2007
|
1.72
|
|
5
|
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
|
J Clin Oncol
|
1995
|
1.72
|
|
6
|
Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.
|
Blood
|
1997
|
1.64
|
|
7
|
The isolation of avian viral RNA and polypeptides.
|
J Biol Chem
|
1979
|
1.21
|
|
8
|
T-cell activation defect in common variable immunodeficiency: restoration by phorbol myristate acetate (PMA) or allogeneic macrophages.
|
Clin Immunol Immunopathol
|
1987
|
1.19
|
|
9
|
Absence of G-CSF receptors and absent response to G-CSF in childhood Burkitt's lymphoma and B-ALL cells.
|
Br J Haematol
|
1995
|
0.86
|
|
10
|
Allo-SCT using BU, CY and melphalan for children with AML in second CR.
|
Bone Marrow Transplant
|
2012
|
0.85
|
|
11
|
Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia.
|
Bone Marrow Transplant
|
2007
|
0.85
|
|
12
|
Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters.
|
Eur J Pediatr
|
1999
|
0.84
|
|
13
|
Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy.
|
Pediatr Transplant
|
2007
|
0.83
|
|
14
|
Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler).
|
Bone Marrow Transplant
|
2005
|
0.83
|
|
15
|
Allogeneic blood SCT for children with Hurler's syndrome: results from the German multicenter approach MPS-HCT 2005.
|
Bone Marrow Transplant
|
2008
|
0.83
|
|
16
|
Differential regulation of stem cell factor mRNA expression in human endothelial cells by bacterial pathogens: an in vitro model of inflammation.
|
Blood
|
1994
|
0.81
|
|
17
|
Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough.
|
Pediatr Transplant
|
2008
|
0.80
|
|
18
|
Severe protein C deficiency and aseptic osteonecrosis of the hip joint: a case report.
|
Eur J Pediatr
|
1999
|
0.78
|
|
19
|
Application of long PCR to detect t(8;14)(q24;q32) translocations in childhood Burkitt's lymphoma and B-ALL.
|
Ann Oncol
|
1997
|
0.78
|
|
20
|
Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT.
|
Am J Transplant
|
2015
|
0.78
|
|
21
|
Variant translocations in sporadic Burkitt's lymphoma detected in fresh tumour material: analysis of three cases.
|
Br J Haematol
|
2000
|
0.77
|
|
22
|
Cerebral venous sinus thrombosis in children with acute lymphoblastic leukemia carrying the MTHFR TT677 genotype and further prothrombotic risk factors.
|
Klin Padiatr
|
1999
|
0.77
|
|
23
|
Invasive fungal infections are responsible for one-fifth of the infectious deaths in children with ALL.
|
Mycoses
|
2003
|
0.77
|
|
24
|
Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with beta-thalassemia.
|
Bone Marrow Transplant
|
2005
|
0.77
|
|
25
|
Human interleukin 2 gene is located on chromosome 4.
|
Cancer Invest
|
1984
|
0.77
|
|
26
|
[NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1: Classification and allocation to strategic therapy groups. BIF study group].
|
Klin Padiatr
|
1994
|
0.75
|
|
27
|
The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia.
|
Bone Marrow Transplant
|
2005
|
0.75
|
|
28
|
Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia.
|
Bone Marrow Transplant
|
2005
|
0.75
|
|
29
|
Interleukin 2: a review.
|
Arzneimittelforschung
|
1985
|
0.75
|
|
30
|
Expression and regulation of c-kit receptor and response to stem cell factor in childhood malignant T-lymphoblastic cells.
|
Leukemia
|
1998
|
0.75
|
|
31
|
Absence of c-kit receptor and absent proliferative response to stem cell factor in childhood Burkitt's lymphoma cells.
|
Blood
|
1995
|
0.75
|
|
32
|
[Detection of translocation t(8;14)(q24;132) in pediatric Burkitt's lymphomas using "long distance" polymerase chain reaction: a new method for diagnosis of Burkitt's lymphomas].
|
Klin Padiatr
|
1997
|
0.75
|
|
33
|
Absence of IL-6 receptor expression in fresh childhood Burkitt's lymphoma cells and induction of IL-6 receptors by Epstein-Barr virus in vitro.
|
Br J Haematol
|
1997
|
0.75
|